
Ondine Biomedical Investor Relations Material
Latest events

Q4 2024
Ondine Biomedical
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Ondine Biomedical Inc
Access all reports
Ondine Biomedical Inc. is a life sciences company specializing in the development of photodisinfection-based therapies. These innovative therapies are designed to provide solutions for a wide range of infections, including those resistant to antibiotics. The company's focus is on creating non-antibiotic anti-infective treatments for bacterial, viral, and fungal infections, leveraging its patented light-activated technology. Ondine Biomedical Inc.'s approach represents a significant advancement in addressing the global challenge of drug-resistant infections, offering potential benefits in both healthcare settings and beyond. The company is headquartered in Vancouver, Canada, and its shares are listed on the London Stock Exchange.
Key slides for Ondine Biomedical Inc


Q4 2024
Ondine Biomedical Inc


H1 2024
Ondine Biomedical Inc
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
OBI
Country
🇬🇧 United Kingdom